Agios Pharmaceuticals, Inc. financial reports, Agios Pharmaceuticals, Inc. annual revenue in 2024. When does Agios Pharmaceuticals, Inc. report revenue?
Agios Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Agios Pharmaceuticals, Inc. net revenue for today is 0 $. The dynamics of Agios Pharmaceuticals, Inc. net revenue fell by -44 045 000 $ compared to the previous report. Net income Agios Pharmaceuticals, Inc. - 1 874 325 000 $. Information about net income is used from open sources. Graph of finance company Agios Pharmaceuticals, Inc.. The financial graph of Agios Pharmaceuticals, Inc. shows the values and changes of such indicators: total assets, net income, net revenue. The value of "net income" Agios Pharmaceuticals, Inc. on the graph is displayed in blue.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
0 $
-100 % ↓
1 874 325 000 $
-
31/12/2020
44 045 000 $
+46.75 % ↑
-97 657 000 $
-
30/09/2020
34 706 000 $
+128.36 % ↑
-98 979 000 $
-
30/06/2020
37 347 000 $
-7.589 % ↓
-90 478 000 $
-
31/03/2019
30 227 000 $
-
-93 078 000 $
-
31/12/2018
30 013 000 $
-
-91 794 000 $
-
30/09/2018
15 198 000 $
-
-94 664 000 $
-
30/06/2018
40 414 000 $
-
-68 745 000 $
-
31/03/2018
8 762 000 $
-
-90 825 000 $
-
31/12/2017
9 799 000 $
-
-88 285 000 $
-
30/09/2017
11 358 000 $
-
-77 137 000 $
-
30/06/2017
11 346 000 $
-
-83 082 000 $
-
Show:
to
Agios Pharmaceuticals, Inc. financial report charts
Dates of Agios Pharmaceuticals, Inc. finance reports: 30/06/2017, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of Agios Pharmaceuticals, Inc. is available online for such a date - 31/03/2021. Gross profit Agios Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Agios Pharmaceuticals, Inc. is -57 667 000 $
Agios Pharmaceuticals, Inc. quarterly report dates
Cost of revenue Agios Pharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Agios Pharmaceuticals, Inc. is 57 667 000 $ Operating income Agios Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Agios Pharmaceuticals, Inc. is -91 217 000 $ Net income Agios Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Agios Pharmaceuticals, Inc. is 1 874 325 000 $
Current assets Agios Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Agios Pharmaceuticals, Inc. is 2 355 114 000 $ Total assets Agios Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Agios Pharmaceuticals, Inc. is 2 488 434 000 $ Current cash Agios Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Agios Pharmaceuticals, Inc. is 1 888 025 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-57 667 000 $
-52 656 000 $
-55 487 000 $
-54 245 000 $
-65 692 000 $
-64 498 000 $
-68 058 000 $
-46 316 000 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
57 667 000 $
96 701 000 $
90 193 000 $
91 592 000 $
95 919 000 $
94 511 000 $
83 256 000 $
86 730 000 $
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
44 045 000 $
34 706 000 $
37 347 000 $
30 227 000 $
30 013 000 $
15 198 000 $
40 414 000 $
8 762 000 $
9 799 000 $
11 358 000 $
11 346 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
30 227 000 $
30 013 000 $
15 198 000 $
40 414 000 $
8 762 000 $
9 799 000 $
11 358 000 $
11 346 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-91 217 000 $
-92 434 000 $
-90 327 000 $
-90 196 000 $
-97 483 000 $
-96 356 000 $
-99 162 000 $
-72 949 000 $
-94 012 000 $
-90 130 000 $
-79 017 000 $
-84 600 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 874 325 000 $
-97 657 000 $
-98 979 000 $
-90 478 000 $
-93 078 000 $
-91 794 000 $
-94 664 000 $
-68 745 000 $
-90 825 000 $
-88 285 000 $
-77 137 000 $
-83 082 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
78 224 000 $
77 216 000 $
72 917 000 $
79 816 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
91 217 000 $
136 479 000 $
125 033 000 $
127 543 000 $
127 710 000 $
126 369 000 $
114 360 000 $
113 363 000 $
102 774 000 $
99 929 000 $
90 375 000 $
95 946 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
2 355 114 000 $
636 677 000 $
669 086 000 $
846 355 000 $
557 095 000 $
613 780 000 $
695 542 000 $
753 782 000 $
802 993 000 $
445 261 000 $
528 307 000 $
604 681 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
2 488 434 000 $
852 952 000 $
908 449 000 $
976 141 000 $
822 131 000 $
858 457 000 $
929 079 000 $
998 235 000 $
1 040 126 000 $
614 397 000 $
687 200 000 $
760 600 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
1 888 025 000 $
127 436 000 $
104 855 000 $
295 858 000 $
103 443 000 $
70 502 000 $
156 478 000 $
210 323 000 $
364 469 000 $
102 724 000 $
132 741 000 $
138 717 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
80 907 000 $
93 503 000 $
84 746 000 $
84 870 000 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
782 450 000 $
423 936 000 $
507 928 000 $
586 042 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
201 874 000 $
170 920 000 $
168 866 000 $
175 093 000 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
24.55 %
19.91 %
18.18 %
17.54 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
2 296 630 000 $
399 500 000 $
480 452 000 $
558 465 000 $
620 257 000 $
687 537 000 $
760 213 000 $
823 142 000 $
865 594 000 $
375 503 000 $
449 806 000 $
508 992 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-103 271 000 $
-74 187 000 $
-63 839 000 $
-67 395 000 $
-99 000 000 $
-74 454 000 $
-77 715 000 $
-58 989 000 $
Last revenue report of Agios Pharmaceuticals, Inc. was 31/03/2021. According to last financial report total revenue in Agios Pharmaceuticals, Inc. was 0 US dollar and changed by -100% since last year. Net income in Agios Pharmaceuticals, Inc. was 1 874 325 000 $ in last quartal, net income changes to 0%.
Agios Pharmaceuticals, Inc. stocks data
AGIO stock price
Agios Pharmaceuticals, Inc. stock price today, AGIO stock quote.
